Endometrial cancer: predictors of response and preferred endocrine therapy.
Amant
F
F
Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, UZ Gasthuisberg, Katholieke Universiteit, Leuven, Belgium.
Leunen
K
K
Neven
P
P
Berteloot
P
P
Vergote
I
I
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D016889:Endometrial Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans
D018931:Antineoplastic Agents, Hormonal